W Resources (LON:WRES) Hits New 52-Week Low at $0.30

Share on StockTwits

W Resources PLC (LON:WRES) shares reached a new 52-week low during trading on Wednesday . The company traded as low as GBX 0.30 ($0.00) and last traded at GBX 0.31 ($0.00), with a volume of 27752984 shares trading hands. The stock had previously closed at GBX 0.32 ($0.00).

The firm has a market cap of $19.18 million and a P/E ratio of -3.05. The company has a debt-to-equity ratio of 205.38, a current ratio of 1.48 and a quick ratio of 1.48. The stock has a 50 day moving average of GBX 0.35 and a 200 day moving average of GBX 0.40.

W Resources Company Profile (LON:WRES)

W Resources Plc engages in the exploration and development of tungsten, tin, copper, and gold properties. Its flagship project is the La Parrilla tungsten project located in Spain. The company was formerly known as Caspian Holdings Plc and changed its name to W Resources Plc in July 2012. W Resources Plc was incorporated in 2004 and is based in London, the United Kingdom.

See Also: How can investors invest in the Euro STOXX 50 Index?

Receive News & Ratings for W Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for W Resources and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

QuickLogic  Downgraded by Zacks Investment Research to Sell
QuickLogic Downgraded by Zacks Investment Research to Sell
Regeneron Pharmaceuticals  Upgraded to “Buy” by BidaskClub
Regeneron Pharmaceuticals Upgraded to “Buy” by BidaskClub
Proofpoint  Raised to “Buy” at BidaskClub
Proofpoint Raised to “Buy” at BidaskClub
Omeros  Upgraded at BidaskClub
Omeros Upgraded at BidaskClub
360 Finance  Rating Increased to Buy at ValuEngine
360 Finance Rating Increased to Buy at ValuEngine
Kiniksa Pharmaceuticals  Downgraded by Zacks Investment Research to “Sell”
Kiniksa Pharmaceuticals Downgraded by Zacks Investment Research to “Sell”


 
© 2006-2020 Zolmax.